Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
出版年份 2019 全文链接
标题
Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
作者
关键词
-
出版物
PHARMACOECONOMICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-01
DOI
10.1007/s40273-019-00835-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study
- (2018) Claire A. Lawson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective
- (2017) Thomas W. Ferguson et al. KIDNEY INTERNATIONAL
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Cost-effectiveness of Antihypertensive Medication
- (2017) Gabriel S. Tajeu et al. MEDICAL CARE
- Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
- (2017) Raymond Vanholder et al. Nature Reviews Nephrology
- Pro: Risk scores for chronic kidney disease progression are robust, powerful and ready for implementation
- (2017) Navdeep Tangri et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe
- (2017) Jonas Hermansson et al. PHARMACOECONOMICS
- Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort
- (2017) Xinyang Hua et al. European Journal of Preventive Cardiology
- Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
- (2016) Anna Trisia Beby et al. ADVANCES IN THERAPY
- Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes
- (2016) Balázs Nagy et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States
- (2016) E. Elbasha et al. JOURNAL OF VIRAL HEPATITIS
- Risk Factors for Development and Progression of Chronic Kidney Disease
- (2016) Wan-Chuan Tsai et al. MEDICINE
- Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore
- (2016) Fan Yang et al. NEPHROLOGY
- Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
- (2016) Hai V. Nguyen et al. BMC Nephrology
- The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
- (2016) Phil McEwan et al. PLoS One
- Value of Lifestyle Intervention to Prevent Diabetes and Sequelae
- (2015) Timothy M. Dall et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Health Economic Evaluation of Paricalcitol® Versus Cincalcet + Calcitriol (Oral) in Italy
- (2015) Mark Nuijten et al. CLINICAL DRUG INVESTIGATION
- Using repeated-prevalence data in multi-state modeling of renal replacement therapy
- (2015) Antoine Dany et al. JOURNAL OF APPLIED STATISTICS
- A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010
- (2015) Katherine T. Mills et al. KIDNEY INTERNATIONAL
- Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease
- (2015) Reiko Okubo et al. Sleep and Breathing
- High-Dose Hemodialysis versus Conventional In-Center Hemodialysis: A Cost-Utility Analysis from a UK Payer Perspective
- (2015) Frank Xiaoqing Liu et al. VALUE IN HEALTH
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Projecting Long-Term Graft and Patient Survival after Transplantation
- (2014) Adrian R. Levy et al. VALUE IN HEALTH
- Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin
- (2014) Katarina Steen Carlsson et al. JOURNAL OF MEDICAL ECONOMICS
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Assessing the cost-effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model
- (2013) P. Thokala et al. DIABETIC MEDICINE
- UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
- (2013) A. J. Hayes et al. DIABETOLOGIA
- Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
- (2013) Kevin F. Erickson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective
- (2013) Charles Christian Adarkwah et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Renal Function Can Improve at Any Stage of Chronic Kidney Disease
- (2013) Lise Weis et al. PLoS One
- External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study
- (2013) Bilal Majed et al. PREVENTIVE MEDICINE
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
- (2013) D. Husereau et al. BMJ-British Medical Journal
- Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)
- (2013) Michael Willis et al. JOURNAL OF MEDICAL ECONOMICS
- Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom
- (2013) Melissa Thompson et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness analysis of timely dialysis referral after renal transplant failure in Spain
- (2012) Guillermo Villa et al. BMC HEALTH SERVICES RESEARCH
- Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension
- (2012) M. Dorenkamp et al. EUROPEAN HEART JOURNAL
- A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study
- (2012) Minako Wakasugi et al. HYPERTENSION RESEARCH
- THE EFFECT OF ENGLISH-LANGUAGE RESTRICTION ON SYSTEMATIC REVIEW-BASED META-ANALYSES: A SYSTEMATIC REVIEW OF EMPIRICAL STUDIES
- (2012) Andra Morrison et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension
- (2012) Benjamin P. Geisler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cost-Effectiveness of Screening for Microalbuminuria among African Americans
- (2012) T. J. Hoerger et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney Function Can Improve in Patients with Hypertensive CKD
- (2012) B. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes
- (2012) Mangala Rajan et al. QUALITY OF LIFE RESEARCH
- The Chronic Kidney Disease Model: A General Purpose Model of Disease Progression and Treatment
- (2011) Lori A Orlando et al. BMC Medical Informatics and Decision Making
- A health economic analysis of clinical islet transplantation
- (2011) Jessica Beckwith et al. CLINICAL TRANSPLANTATION
- Has the incidence of end-stage renal disease in the USA and other countries stabilized?
- (2011) Paul W Eggers CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
- (2011) William G. Couser et al. KIDNEY INTERNATIONAL
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Should eGFR and Albuminuria Be Added to the Framingham Risk Score? Chronic Kidney Disease and Cardiovascular Disease Risk Prediction
- (2011) Alex Chang et al. NEPHRON CLINICAL PRACTICE
- Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach
- (2011) Swapnil Hiremath et al. PLoS One
- PUK26 THE INFLUENCE OF FUTURE UNRELATED COSTS ON COSTEFFECTIVENESS ESTIMATES:TREATMENT OF HYPERPHOSPHATEMIA WITH LANTHANUM CARBONATE IN PRE-DIALYIS PATIENTS WITH CHRONIC KIDNEY DISEASE
- (2011) S Vegter et al. VALUE IN HEALTH
- Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
- (2011) Stefan Vegter et al. VALUE IN HEALTH
- Cost–effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease
- (2011) Charles Christian Adarkwah et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis
- (2011) Huseyin Naci et al. JOURNAL OF MEDICAL ECONOMICS
- An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
- (2010) Fiona M. Clement et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences
- (2010) Thomas J. Hoerger et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK
- (2010) Mark Nuijten et al. CLINICAL DRUG INVESTIGATION
- Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands
- (2010) Cornelis Boersma et al. CLINICAL THERAPEUTICS
- Risk factors for progression of chronic kidney disease
- (2010) Amy Staples et al. CURRENT OPINION IN PEDIATRICS
- Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease
- (2010) Yasuaki Hayashino et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care
- (2010) M. Y. Bertram et al. DIABETOLOGIA
- Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the ‘old’ versus the ‘new’ Framingham equation
- (2010) Ella Zomer et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany
- (2010) Charles Christian Adarkwah et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Early recognition and prevention of chronic kidney disease
- (2010) Matthew T James et al. LANCET
- Weight Loss Interventions in Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2009) S. D. Navaneethan et al. Clinical Journal of the American Society of Nephrology
- Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective
- (2009) Mark Nuijten et al. CURRENT MEDICAL RESEARCH AND OPINION
- Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD
- (2009) S. I. Hallan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The cost-effectiveness of increasing kidney transplantation and home-based dialysis
- (2009) KIRSTEN HOWARD et al. NEPHROLOGY
- Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
- (2009) Kirsten Howard et al. VALUE IN HEALTH
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
- (2008) S. Basi et al. DIABETES CARE
- Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications
- (2008) J. Chen et al. DIABETES OBESITY & METABOLISM
- Cost-Utility Analysis of Antihypertensive Combination Therapy in Japan by a Monte Carlo Simulation Model
- (2008) Ikuo SAITO et al. HYPERTENSION RESEARCH
- Cost-effectiveness of the oral adsorbent AST-120versusplacebo for chronic kidney disease
- (2008) TOMOHIKO TAKAHASHI et al. NEPHROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started